Wellington Management Group
AVBP icon

Wellington Management Group’s ArriVent BioPharma AVBP Stock Holding History

Wellington Management Group’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
100,855
+22,642
+29% +$668K ﹤0.01% 1523
2026
Q1 		$1.8M Sell
78,213
-4,065
-5% -$91.8K ﹤0.01% 1572
2025
Q4 		$1.66M Buy
82,278
+532
+0.7% +$11.1K ﹤0.01% 1637
2025
Q3 		$1.51M Buy
81,746
+15,417
+23% +$303K ﹤0.01% 1707
2025
Q2 		$1.44M Buy
66,329
+4,981
+8% +$103K ﹤0.01% 1652
2025
Q1 		$1.13M Buy
61,348
+19,427
+46% +$475K ﹤0.01% 1678
2024
Q4 		$1.12M Buy
+41,921
New +$1.2M ﹤0.01% 1697

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group's AVBP Position: Q2 2026 in Review

Wellington Management Group increased its ArriVent BioPharma (AVBP) stake by 29% in Q2 2026, buying an estimated $668K and bringing the position to 100,855 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1523.

Wellington Management Group first reported a position in AVBP in Q4 2024 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Wellington Management Group held 100,855 shares of ArriVent BioPharma worth $3.5M as of Q2 2026.
  • Wellington Management Group bought 22,642 ArriVent BioPharma shares in Q2 2026, an estimated $668K.
  • ArriVent BioPharma made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1523 holding.
  • Wellington Management Group first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.